ppa

primary progressive aphasia

Alternative Treatments

Practitioners of complementary and alternative medicine (CAM) use health care practices and products that are not considered a part of the conventional medicine practiced by holders of MD (medical doctor), DO (doctor of osteopathy), nursing and therapy degrees. The list of treatments considered CAM evolves regularly as therapies that are proven to be safe and effective in clinical trials become mainstream health care. It is important to remember herbal and alternative treatments may interact with prescribed or non prescription medications, and as with all treatments, possess the potential for side effects.

Using herbal treatments

Herbs are typically used in combination with each other and usually do not have serious side effects when used appropriately at suggested doses. It is not unusual for an individual to use complementary medicine and conventional medicine at the same time.

The risks of herbal treatments

Reducing Cognitive Impairment after Surgery

Older patients with neurodegenerative disease quite often need surgery for reasons unrelated to their cognitive problems. Both the hospital and surgical environments can be challenging for patients, but with some planning, these difficulties can be minimized. The suggestions that follow are not all inclusive, and we suggest discussing suggestions your physician/s may have prior to any surgical procedure.

Older patients with neurodegenerative disease quite often need surgery for reasons unrelated to their cognitive problems. Both the hospital and surgical environments can be challenging for patients, but with some planning, these difficulties can be minimized. The suggestions that follow are not all inclusive, and we suggest discussing suggestions your physician/s may have prior to any surgical procedure.

Medications to Avoid

It is always good try to non-drug interventions before turning to medications but sometimes medications are necessary. Certain types of medications may actually increase confusion, and people with cognitive problems may be particularly sensitive to these effects. In addition, they may interfere with the medications used to treat cognitive problems.

It is always good try to non-drug interventions before turning to medications but sometimes medications are necessary. Certain types of medications may actually increase confusion, and people with cognitive problems may be particularly sensitive to these effects. In addition, they may interfere with the medications used to treat cognitive problems. Below is information about medications to try to avoid if you have cognitive problems.

Anxiety

What medications are commonly used for anxiety?

Raquel C. Gardner, MD

Clinical Instructor and Behavioral Neurology Fellow

Dr. Gardner completed her bachelor's degree in Neuroscience and Behavior at Columbia University in New York. She received her medical degree from Harvard University. She completed her internship in internal medicine and residency in neurology at UCSF. She then joined the UCSF Memory and Aging Center in 2012 where she is a Clinical Instructor and a Behavioral Neurology Fellow. As a neurologist, Dr. Gardner evaluates and treats patients with various neurodegenerative disorders and provides them with follow-up care. Her current research focuses on understanding cognitive, motor, and psychiatric sequelae of traumatic brain injury in older adults.

Joy Lee

Clinic Coordinator

Joy Lee is a clinic coordinator for the Memory and Aging Center. She is a certified Phlebotomy Technician (2008), studied medical terminology and is a certified medical biller and coder (2009). She has five years of dental background at the UCSF School of Dentistry and over seven years of experience in administrative and clerical support. She would like to pursue her career in the Memory and Aging Center. And she loves to bake!

Carrie Cheung

Clinic Coordinator

Carrie, a San Francisco native, comes from a sales and public service background with over 10 years of management. She graduated from San Francisco State University with a creative writing degree and a minor in holistic health. She enjoys helping the public, learning new cultures and challenges, and writing about her experiences.

Dena Dubal, MD, PhD

Assistant Professor of Neurology

Dr. Dubal received her medical and doctorate degrees from the University of Kentucky College of Medicine. Her graduate research with Dr. Phyllis Wise focused on effects of hormones on stroke injury. Dr. Dubal completed a medical internship and neurology residency at UCSF, where she also served as chief resident. She then trained with Drs. Lennart Mucke and Bruce Miller, who shared the 2011 Potamkin Prize in Neurodegeneration. Dr. Dubal is an Assistant Professor of Neurology at UCSF and directs the Laboratory of Neuroscience and Aging research. Her laboratory's research focus is on how to slow or block aging to prevent diseases of the aging brain, such as Alzheimer's. She is a recipient of the Paul Beeson Career Development Award through the NIA and American Federation for Aging Research.

Information on Dr. Dubal's Laboratory for Neuroscience and Aging Research can be accessed at www.duballab.org.

Georges Naasan, MD

Neurologist, Clinical Instructor

Dr. Georges Naasan received his medical degree from the American University of Beirut in Lebanon. He completed an internship in medicine and a residency in neurology at Case Western Reserve University, University Hospitals of Cleveland. He joined the UCSF Memory and Aging Center in 2011 where he is a Clinical Instructor and a Behavioral Neurology Fellow.

As a neurologist, Dr. Naasan evaluates patients and research participants with various neurodegenerative disorders through a multidisciplinary approach and provides follow-up care. He is particularly interested in the psychotic manifestations of neurodegenerative diseases such as hallucinations and delusions. During his residency, he used functional MRI imaging techniques to study the anatomy of misidentification delusions such as the Capgras syndrome.

Alissa Nana Li, PhD

Postdoctoral Fellow

Alissa joined the Seeley Selective Vulnerability Research Laboratory in 2011 as a post-doctoral fellow. Her background is in neurodegeneration research. Alissa completed a BSc degree with honors in biomedical science in 2004 and a PhD degree in anatomy in 2009 from the University of Auckland, New Zealand, where she investigated the variable pattern of cortical neuronal loss in Huntington’s disease. In the Seeley lab she is investigating the selective vulnerability of von Economo neurons (VENs) in frontotemporal dementia.

Syndicate content